Volatile Organic Compounds Associated with SARS CoV 2 Infection
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5093Copied!
Version20221207Copied!
PublisherClinical ArchitectureDate2023-06-21T18:16:37-04:00Purpose(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)
Expansion
| Code | Display | System |
|---|---|---|
| 100342-5 | http://loinc.org |
systemhttp://loinc.org
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://loinc.org",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 1
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2023-06-21T18:16:37-04:00",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2022-12-07T01:03:35.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "Clinical Architecture",
"jurisdiction" : [ {
"extension" : [ {
"valueString" : "UNKNOWN",
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
} ]
} ],
"purpose" : "(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)",
"name" : "VolatileOrganicCompoundsAssociatedWithSARSCoV2Infection",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://loinc.org",
"code" : "100342-5",
"display" : "Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry",
"version" : "2.74"
} ],
"offset" : 0,
"total" : 1,
"identifier" : "urn:uuid:cd9d2bc4-d3c3-49db-92dc-556ee064354c",
"timestamp" : "2023-06-29T20:35:13-04:00",
"parameter" : [ {
"name" : "count",
"valueInteger" : 1000
}, {
"name" : "offset",
"valueInteger" : 0
} ]
},
"title" : "Volatile Organic Compounds Associated with SARS CoV 2 Infection",
"extension" : [ {
"valueString" : "Clinical Architecture",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2023-06-21",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-12-07",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "7fb56993-9478-4b95-a65c-e7285384c17e",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5093",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.5093"
} ],
"version" : "20221207"
}